HUTCHMED (China) Ltd (HCM)
HUTCHMED Market Cap: 3.444B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 3.444B |
May 16, 2024 | 3.578B |
May 15, 2024 | 3.679B |
May 14, 2024 | 3.654B |
May 13, 2024 | 3.718B |
May 10, 2024 | 3.713B |
May 09, 2024 | 3.555B |
May 08, 2024 | 3.324B |
May 07, 2024 | 3.321B |
May 06, 2024 | 3.384B |
May 03, 2024 | 3.269B |
May 02, 2024 | 3.339B |
May 01, 2024 | 3.203B |
April 30, 2024 | 3.160B |
April 29, 2024 | 3.228B |
April 26, 2024 | 3.100B |
April 25, 2024 | 3.242B |
April 24, 2024 | 3.143B |
April 23, 2024 | 3.116B |
April 22, 2024 | 2.892B |
April 19, 2024 | 2.817B |
April 18, 2024 | 2.793B |
April 17, 2024 | 2.808B |
April 16, 2024 | 2.848B |
April 15, 2024 | 3.015B |
Date | Value |
---|---|
April 12, 2024 | 3.053B |
April 11, 2024 | 3.088B |
April 10, 2024 | 3.010B |
April 09, 2024 | 3.063B |
April 08, 2024 | 2.880B |
April 05, 2024 | 2.793B |
April 04, 2024 | 2.880B |
April 03, 2024 | 2.890B |
April 02, 2024 | 2.855B |
April 01, 2024 | 2.863B |
March 28, 2024 | 2.868B |
March 27, 2024 | 2.877B |
March 26, 2024 | 2.843B |
March 25, 2024 | 2.870B |
March 22, 2024 | 2.798B |
March 21, 2024 | 2.948B |
March 20, 2024 | 2.960B |
March 19, 2024 | 2.918B |
March 18, 2024 | 2.925B |
March 15, 2024 | 3.007B |
March 14, 2024 | 2.865B |
March 13, 2024 | 3.169B |
March 12, 2024 | 2.788B |
March 11, 2024 | 2.554B |
March 08, 2024 | 2.539B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Global Pharmatech Inc | 3.542M |
Sino Biopharmaceutical Ltd | 6.765B |
Pharmaron Beijing Co Ltd | 2.493B |
Regencell Bioscience Holdings Ltd | 67.80M |
Prenetics Global Ltd | 70.91M |
Market Cap Related Metrics
PE Ratio | 36.67 |
PS Ratio | 4.184 |
Price to Book Value | 4.714 |
Price to Free Cash Flow | 18.79 |
Price | 20.17 |
Earnings Yield | 2.73% |
Operating PE Ratio | 190.82 |
Normalized PE Ratio | 36.67 |